Melanoma identification and classification model based on fine-tuned convolutional neural network

Abstract

Background: Breakthroughs in skin cancer diagnostics have resulted from recent image recognition and Artificial Intelligence (AI) technology advancements. There has been growing recognition that skin cancer can be lethal to humans. For instance, melanoma is the most unpredictable and terrible form of skin cancer. Materials and Methodology: This paper aims to support Internet of Medical Things (IoMT) applications by developing a robust image classification model for the early detection of melanoma, a deadly skin cancer. It presents a novel approach to melanoma detection using a Convolutional Neural Network (CNN)-based method that employs image classification techniques based on Deep Learning (DL). We analyze dermatoscopic images from publicly available datasets, including DermIS, DermQuest, DermIS&Quest, and ISIC2019. Our model applies convolutional and pooling layers to extract meaningful features, followed by fully connected layers for classification. Results: The proposed CNN model achieves high accuracy demonstrates the model’s effectiveness in distinguishing between malignant and benign skin lesions. We developed deep features and used transfer learning to improve the categorization accuracy of medical images. Soft-max classification layer and support vector machine have been used to assess the classification performance of deep features. The proposed model’s efficacy is rigorously evaluated using benchmark datasets: DermIS, DermQuest, and ISIC2019, having 621, 1233, and 25000 images, respectively. Its performance is compared to current best practices showing an average of 5% improved detection accuracy in DermIS, 6% improvement in DermQuest, and 0.81% in ISIC2019 datasets. Conclusion: Our study showcases the potential of CNN in melanoma detection, contributing to early diagnosis and improved patient outcomes. The developed model proves its capability to aid dermatologists in accurate decision-making, paving the way for enhanced skin cancer diagnosis.